Serious liver disease induced by infliximab
Infliximab, a chimeric monoclonal antibody that binds the tumor necrosis factor ? (TNF?), is used in the treatment of rheumatoid arthritis (RA) and Crohn’s disease (CD). Previous cases of significant secondary liver disease associated with infliximab treatment have been reported in patients with RA,...
Autores Principales: | , , , , |
---|---|
Formato: | Artículo (Article) |
Lenguaje: | Inglés (English) |
Publicado: |
Springer Nature
2006
|
Materias: | |
Acceso en línea: | https://repository.urosario.edu.co/handle/10336/25955 https://doi.org/10.1007/s10067-005-0169-y |